Akums Drugs and Pharmaceuticals Ltd (AKUM)

Currency in INR
504.60
-10.25(-1.99%)
Closed·
AKUM Scorecard
Full Analysis
Prominent player in the Life Sciences Tools & Services industry
AKUM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
503.00514.25
52 wk Range
407.401,174.85
Key Statistics
Bid/Ask
504.60 / 505.45
Prev. Close
514.85
Open
512.15
Day's Range
503-514.25
52 wk Range
407.4-1,174.85
Volume
11.52K
Average Volume (3m)
16.26K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AKUM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Akums Drugs and Pharmaceuticals Ltd Company Profile

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiology, orthopaedics, pediatrics, and dermatology, as well as anti-infectives, pain management and gastroenterology. In addition, the company operates as pharmaceutical contract development and manufacturing company. The company was incorporated in 2004 and is based in Delhi, India.

Employees
7536
Market
India

Compare AKUM to Peers and Sector

Metrics to compare
AKUM
Peers
Sector
Relationship
P/E Ratio
23.3x34.6x−0.5x
PEG Ratio
0.001.020.00
Price/Book
2.6x4.5x2.6x
Price / LTM Sales
1.9x4.9x3.3x
Upside (Analyst Target)
37.9%3.4%45.1%
Fair Value Upside
Unlock5.0%7.4%Unlock

Earnings

Latest Release
May 26, 2025
EPS / Forecast
8.90 / --
Revenue / Forecast
10.56B / --
EPS Revisions
Last 90 days

AKUM Income Statement

People Also Watch

602.60
TNSL
-2.32%
1,502.20
RAIB
-1.60%
1,337.00
UNSP
+1.10%
1,298.00
RRKA
-2.72%

FAQ

What Stock Exchange Does Akums Drugs and Pharmaceuticals Ltd Trade On?

Akums Drugs and Pharmaceuticals Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Akums Drugs and Pharmaceuticals Ltd?

The stock symbol for Akums Drugs and Pharmaceuticals Ltd is "AKUM."

What Is the Akums Drugs and Pharmaceuticals Ltd Market Cap?

As of today, Akums Drugs and Pharmaceuticals Ltd market cap is 78.68B.

What Is Akums Drugs and Pharmaceuticals Ltd's Earnings Per Share (TTM)?

The Akums Drugs and Pharmaceuticals Ltd EPS (TTM) is 22.60.

When Is the Next Akums Drugs and Pharmaceuticals Ltd Earnings Date?

Akums Drugs and Pharmaceuticals Ltd will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is AKUM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Akums Drugs and Pharmaceuticals Ltd Stock Split?

Akums Drugs and Pharmaceuticals Ltd has split 0 times.

How Many Employees Does Akums Drugs and Pharmaceuticals Ltd Have?

Akums Drugs and Pharmaceuticals Ltd has 7536 employees.

What is the current trading status of Akums Drugs and Pharmaceuticals Ltd (AKUM)?

As of 04 Aug 2025, Akums Drugs and Pharmaceuticals Ltd (AKUM) is trading at a price of 504.60, with a previous close of 514.85. The stock has fluctuated within a day range of 503.00 to 514.25, while its 52-week range spans from 407.40 to 1,174.85.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.